A One Year Double-blind Trial to Investigate the Efficacy and Safety of Meloxicam Oral Suspension in Juvenile Rheumatoid Arthritis (JRA/JIA)

Univ.-Klinik für Kinder- und Jugendheilkunde Wien, Vienna

Boehringer Ingelheim Investigational Site, Merksem

U.Z. Gasthuisberg, Leuven

Landes-Kinderklinik Linz, Linz

UZ Gent, Ghent

Istituto G. Gaslini, Genova

Istituto Ortopedico Gaetano Pini, Milan

Boehringer Ingelheim Investigational Site, Hamburg

Rheumaklinik Bad Bramstedt GmbH, Bad Bramstedt

IRCCS Policlinico San Matteo, Pavia

Neurologie, Bremen

IRCCS Burlo Garofalo, Trieste

Clinica Pediatrica I, Padua

Ospedale Meyer, Florence

II Università degli Studi di Napoli, Napoli

Università Federico II, Napoli

Universität Erlangen, Erlangen

Bayrische Julius-Maximilians-Universität, Würzburg

Institute of Rheumatology of RAMN, Moscow

Medical Faculty of Russian People Friendship University, Moscow

Scientific Research Institute of Pediatric Hematology, Moscow

Medical Academy Setchenov, Moscow

Gottfried Preyersches Kinderspital d. Stadt Wien, Vienna

Boehringer Ingelheim Investigational Site, Angers

Boehringer Ingelheim Investigational Site, Lille

Boehringer Ingelheim Investigational Site, Marseille

Boehringer Ingelheim Investigational Site, Paris

Boehringer Ingelheim Investigational Site, Strasbourg

Boehringer Ingelheim Investigational Site, Vandœuvre-lès-Nancy

Martin-Luther-Universität Halle, Halle

Ospedale Pediatrico Bambin Gesù, Roma

Dept. of Child Health, London

Booth Hall Childrens Hospital, Manchester

Paediatric Department, Wolverhampton